Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 293

Results For "market"

3695 News Found

Evonik invests in US-based 3D screen printing technology firm Laxxon Medical
News | March 07, 2022

Evonik invests in US-based 3D screen printing technology firm Laxxon Medical

Laxxon Medical has developed a 3D screen printing technology for the manufacture of structured tablets that enables the controlled release of active pharmaceutical ingredients over time


Bone Biologics enters into supply agreement with MTF Biologics for demineralized bone matrix
Biotech | March 07, 2022

Bone Biologics enters into supply agreement with MTF Biologics for demineralized bone matrix

This supply agreement provides material for the company’s planned 30-patient pilot study, and later for its planned U.S. pivotal study in spine fusion patients


NATCO launches first generic version of Revlimid in the US
Drug Approval | March 07, 2022

NATCO launches first generic version of Revlimid in the US

NATCO and Teva are launching these strengths of lenalidomide pursuant to a license of patents owned by Celgene


Kilitch Drugs earmarks Rs. 100 crore as part of its expansion
News | March 06, 2022

Kilitch Drugs earmarks Rs. 100 crore as part of its expansion

The company plans to establish a state-of-the-art greenfield pharma facility with a total of 4-6 manufacturing units in different therapeutics categories to cater to domestic and export markets


Evonik expands production of plant-derived cholesterol in Germany
News | March 06, 2022

Evonik expands production of plant-derived cholesterol in Germany

The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol


USFDA issues final guidance on voluntary recalls
News | March 04, 2022

USFDA issues final guidance on voluntary recalls

The guidance also urges companies to act quickly to initiate a recall when public health is at risk and to do so prior to completing an investigation into the cause of the problem


WuXi STA passes EMA drug product pre-approval inspection at its Wuxi City site
Biotech | March 04, 2022

WuXi STA passes EMA drug product pre-approval inspection at its Wuxi City site

WuXi STA’s drug product site in Wuxi City offers a full range of services including formulation development and manufacturing for a broad range of oral and injectable dosage forms


Limited impact of short-term disruptions, growth momentum to continue in FY 23
News | March 03, 2022

Limited impact of short-term disruptions, growth momentum to continue in FY 23

Large players are adequately capitalised to make bigger investments to adjust for the ongoing fundamental shift in market opportunities


Alkem licenses technology from Harvard to treat ischemic injury and vascular diseases
Biotech | March 03, 2022

Alkem licenses technology from Harvard to treat ischemic injury and vascular diseases

Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy


Brinton ties up with Scholl Wellness Company
News | March 03, 2022

Brinton ties up with Scholl Wellness Company

Brinton Pharmaceuticals enters exclusive sales and distribution rights of Scholl foot care products including Krack cream